0001140361-17-033117.txt : 20170823
0001140361-17-033117.hdr.sgml : 20170823
20170823172043
ACCESSION NUMBER: 0001140361-17-033117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170821
FILED AS OF DATE: 20170823
DATE AS OF CHANGE: 20170823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAPLAN ANDREW J
CENTRAL INDEX KEY: 0001582246
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33675
FILM NUMBER: 171047738
MAIL ADDRESS:
STREET 1: SUITE 200 623 RIVER ROAD
CITY: FAIR HAVEN
STATE: NJ
ZIP: 07704
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioptix, Inc.
CENTRAL INDEX KEY: 0001167419
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 841553387
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 834-F SOUTH PERRY STREET, SUITE 443
CITY: CASTLE ROCK
STATE: CO
ZIP: 80104
BUSINESS PHONE: 303-794-2000
MAIL ADDRESS:
STREET 1: 834-F SOUTH PERRY STREET, SUITE 443
CITY: CASTLE ROCK
STATE: CO
ZIP: 80104
FORMER COMPANY:
FORMER CONFORMED NAME: Venaxis, Inc.
DATE OF NAME CHANGE: 20121218
FORMER COMPANY:
FORMER CONFORMED NAME: AspenBio Pharma, Inc.
DATE OF NAME CHANGE: 20051110
FORMER COMPANY:
FORMER CONFORMED NAME: ASPENBIO INC
DATE OF NAME CHANGE: 20020213
4
1
doc1.xml
FORM 4
X0306
4
2017-08-21
0
0001167419
Bioptix, Inc.
BIOP
0001582246
KAPLAN ANDREW J
C/O BIOPTIX, INC.
834-F SOUTH PERRY STREET, SUITE 443
CASTLE ROCK
CO
80104
1
0
0
0
Common Stock
2017-08-21
4
A
0
10000
0.00
A
2916
D
Represents a restricted stock award under the Bioptix, Inc. Amended & Restated Equity Incentive Plan (the "Restricted Stock Award"), which shall vest in 24 equal monthly installments over a two year period, beginning on the one month anniversary of the date of issuance. The vesting of the Restricted Stock Award is subject to acceleration upon the occurrence of a "Qualifying Transaction", as such term is defined in the Restricted Stock Award.
Restricted Stock Award is compensation for the Reporting Person's service on the Board.
Represents shares vested or to be vested within 60 days pursuant to restricted stock awards.
/s/ Andrew Kaplan
2017-08-23